News: Cancer News

Next Page »

Colon cancer’s protein signatures identified

Friday, July 25th, 2014

by Bill Snyder A Vanderbilt University-led research team has identified protein “signatures” of genetic mutations that drive colorectal cancer, the nation’s second leading cause of cancer deaths after lung cancer. The technological tour de force, described as the first integrated “proteogenomic” characterization of human cancer, was reported online this week by the journal Nature. It […]

Research bolstered by lung cancer foundation

Monday, July 21st, 2014

by Dagny Stuart The LUNGevity Foundation has awarded a 2014 Career Development Award for Translational Research to Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology. Lovly is one of three recipients of the annual grants, which provide $300,000 over three years for lung cancer research. “This is a wonderful award and I […]

VICC researchers in national spotlight

Wednesday, June 25th, 2014

by Dagny Stuart Early research suggests patients with advanced melanoma — the most deadly form of skin cancer — may benefit from both immunotherapies and targeted therapies aimed at specific gene mutations. However, no combinations of these two classes of drugs have been shown to be safe, so far. The results of the first such […]

Rising Tobacco Epidemic in Asia

Tuesday, June 10th, 2014

A new study estimates that tobacco smoking has been linked to approximately 2 million deaths among adult men and women in Asia in recent years and predicts a rising death toll. The study, published in PLOS Medicine, was led by Wei Zheng, M.D., Ph.D., MPH, professor of Medicine and director of the Vanderbilt Epidemiology Center, […]

My Cancer Genome launches new mobile app

Friday, May 30th, 2014

by Dagny Stuart My Cancer Genome, an online precision cancer medicine tool developed by researchers at Vanderbilt-Ingram Cancer Center, has unveiled an updated free mobile app that provides even more information about genetic alterations in various types of cancer and the therapies available to treat those alterations. The new MCG mobile app is searchable and […]

Arteaga Assumes AACR Post

Tuesday, April 22nd, 2014

Carlos L. Arteaga, M.D., professor of Medicine and Cancer Biology and Donna S. Hall Professor of Breast Cancer Research at Vanderbilt-Ingram Cancer Center, has assumed the presidency of the American Association for Cancer Research (AACR) for 2014-2015. He was inaugurated during the AACR Annual Meeting which was held April 5-9, in San Diego. AACR, founded […]

Martell Foundation Honors VICC Leaders

Monday, March 24th, 2014

Scott Hiebert, Ph.D., associate director of Basic Research at Vanderbilt-Ingram Cancer Center, was celebrated for his contributions to cancer research during the 6th Annual Nashville Honors Gala benefiting the T. J. Martell Foundation. This year’s event at Nashville’s Omni Hotel honored five Nashville community leaders who work diligently to make a difference in the community, […]

VICC Offers Lung Cancer Screens

Thursday, February 27th, 2014

Vanderbilt-Ingram Cancer Center has launched a new lung cancer screening program to provide low-dose CT scans for patients at high risk for the deadly disease. Current or former smokers ages 55 to 74 who have a history of 30 or more pack years of smoking are eligible for the scans. A pack year is defined […]

Breast SPORE Grant Renewed Again

Wednesday, November 27th, 2013

Vanderbilt-Ingram Cancer Center’s Breast Specialized Program of Research Excellence (SPORE) has been awarded a third round of funding from the National Cancer Institute (NCI). The SPORE grant renewal will provide more than $11.3 million in funding support over the next five years for breast cancer research. “It is becoming uncommon for a cancer center to […]

NIH Grant Supports Colon Research

Friday, August 16th, 2013

Robert Coffey Jr., M.D., Ingram Professor of Cancer Research at Vanderbilt University, has received a five-year, $5.2 million grant from the National Institutes of Health (NIH) to study the role of extracellular RNA (ex-RNA) in colorectal cancer. Most RNA works inside cells to translate genes into proteins that are necessary for organisms to function. Now, recent […]